| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Business Officer | EVP, Cbo, GC &Secretary | SVP, Ops, Bus Dev, GC &Sec +1 more
2 companies
Primiano Christopher Brett is a Chief Business Officer at AURA with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 1 sell.
Estimated insider holdings value: $102K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 9, 2016 | KPTI Karyopharm Therapeutics Inc. | SVP,Corp Dev,Gen Counsel&Sec. | Sell | 4,342 | $8.19 | $35,544.48 | -21.5% |